Acute fulminant hepatitis B during hepatitis C virus therapy with direct-acting antivirals in a patient co-infected with HIV
Enferm Infecc Microbiol Clin. 2017 Dec;35(10):681-682.
doi: 10.1016/j.eimc.2017.02.003.
Epub 2017 Mar 31.
[Article in
English,
Spanish]
Affiliations
- 1 Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, España. Electronic address: [email protected].
- 2 Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, España.
No abstract available
MeSH terms
-
Anti-HIV Agents / therapeutic use
-
Antiviral Agents / therapeutic use*
-
Benzimidazoles / therapeutic use*
-
Coinfection
-
Drug Substitution
-
Fatal Outcome
-
Fluorenes / therapeutic use*
-
HIV Infections / complications*
-
HIV Infections / drug therapy
-
Hepacivirus / isolation & purification
-
Hepatitis B virus / isolation & purification
-
Hepatitis B virus / physiology*
-
Hepatitis B, Chronic / complications*
-
Hepatitis C, Chronic / complications*
-
Hepatitis C, Chronic / drug therapy
-
Humans
-
Interferon alpha-2 / therapeutic use
-
Liver Failure, Acute / etiology*
-
Male
-
Middle Aged
-
Oligopeptides / therapeutic use
-
Ribavirin / therapeutic use
-
Sofosbuvir / therapeutic use*
-
Virus Activation*
Substances
-
Anti-HIV Agents
-
Antiviral Agents
-
Benzimidazoles
-
Fluorenes
-
Interferon alpha-2
-
Oligopeptides
-
ledipasvir
-
Ribavirin
-
telaprevir
-
Sofosbuvir